Skip to main content

Sage Therapeutics, Inc. (NASDAQ: SAGE) Investor Securities Class Action Lawsuit 08/28/2024

  • If you purchased a significant amount of shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) between April 12, 2021 and July 23, 2024, and / or if you purchased any NASDAQ: SAGE shares prior to April 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 28, 2024. NASDAQ: SAGE investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 28, 2024 - An investor in shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Sage Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between April 12, 2021 and July 23, 2024. Cambridge, MA based Sage Thera...



You must register (for free) or login to view the entire case.